LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 73 filers reported holding LEGEND BIOTECH CORP in Q1 2021. The put-call ratio across all filers is 3.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,938,000 | -97.2% | 47,500 | -96.2% | 0.02% | -96.8% |
| Q2 2022 | $69,237,000 | +48.7% | 1,258,850 | -1.8% | 0.52% | -16.7% |
| Q1 2022 | $46,564,000 | -46.8% | 1,281,350 | -31.7% | 0.63% | -29.2% |
| Q4 2021 | $87,457,000 | -7.9% | 1,876,350 | -0.1% | 0.89% | -31.0% |
| Q3 2021 | $94,987,000 | +23.2% | 1,878,708 | +0.0% | 1.29% | +38.2% |
| Q2 2021 | $77,107,000 | +22.6% | 1,878,374 | -13.3% | 0.93% | +20.3% |
| Q1 2021 | $62,894,000 | -59.2% | 2,167,274 | -60.4% | 0.78% | -6.6% |
| Q4 2020 | $154,046,000 | +82.9% | 5,470,412 | +93.6% | 0.83% | -33.7% |
| Q3 2020 | $84,215,000 | -30.8% | 2,825,806 | -7.5% | 1.25% | -41.2% |
| Q2 2020 | $121,757,000 | – | 3,056,342 | – | 2.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |